Stock Analysis

What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?

XTRA:ILM1
Source: Shutterstock

Today we'll look at Medios AG (ETR:ILM1) and reflect on its potential as an investment. To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business.

First up, we'll look at what ROCE is and how we calculate it. Then we'll compare its ROCE to similar companies. And finally, we'll look at how its current liabilities are impacting its ROCE.

Understanding Return On Capital Employed (ROCE)

ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. All else being equal, a better business will have a higher ROCE. In brief, it is a useful tool, but it is not without drawbacks. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

How Do You Calculate Return On Capital Employed?

Analysts use this formula to calculate return on capital employed:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Medios:

0.17 = €15m ÷ (€117m - €29m) (Based on the trailing twelve months to December 2019.)

So, Medios has an ROCE of 17%.

View our latest analysis for Medios

Is Medios's ROCE Good?

ROCE can be useful when making comparisons, such as between similar companies. Medios's ROCE appears to be substantially greater than the 6.8% average in the Healthcare industry. I think that's good to see, since it implies the company is better than other companies at making the most of its capital. Separate from Medios's performance relative to its industry, its ROCE in absolute terms looks satisfactory, and it may be worth researching in more depth.

Medios reported an ROCE of 17% -- better than 3 years ago, when the company didn't make a profit. This makes us wonder if the company is improving. You can see in the image below how Medios's ROCE compares to its industry. Click to see more on past growth.

XTRA:ILM1 Past Revenue and Net Income June 22nd 2020
XTRA:ILM1 Past Revenue and Net Income June 22nd 2020

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. ROCE can be deceptive for cyclical businesses, as returns can look incredible in boom times, and terribly low in downturns. This is because ROCE only looks at one year, instead of considering returns across a whole cycle. What happens in the future is pretty important for investors, so we have prepared a free report on analyst forecasts for Medios.

What Are Current Liabilities, And How Do They Affect Medios's ROCE?

Short term (or current) liabilities, are things like supplier invoices, overdrafts, or tax bills that need to be paid within 12 months. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

Medios has current liabilities of €29m and total assets of €117m. Therefore its current liabilities are equivalent to approximately 25% of its total assets. Low current liabilities are not boosting the ROCE too much.

Our Take On Medios's ROCE

With that in mind, Medios's ROCE appears pretty good. There might be better investments than Medios out there, but you will have to work hard to find them . These promising businesses with rapidly growing earnings might be right up your alley.

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.